Researchers with the Office of Prescription Drug Promotion (OPDP) are again looking at the effect of proprietary names on consumers and prescribers. The new research builds upon and extends OPDP research on the promotional implications of proprietary prescription drug names, which was first proposed in January 2020. That research involves an experimental design intended to a... Read More